344 related articles for article (PubMed ID: 18362097)
1. Cognitive deficits and striato-frontal dopamine release in Parkinson's disease.
Sawamoto N; Piccini P; Hotton G; Pavese N; Thielemans K; Brooks DJ
Brain; 2008 May; 131(Pt 5):1294-302. PubMed ID: 18362097
[TBL] [Abstract][Full Text] [Related]
2. [Functional mapping of dopaminergic transmission].
Sawamoto N
Rinsho Shinkeigaku; 2007 Nov; 47(11):832-4. PubMed ID: 18210810
[TBL] [Abstract][Full Text] [Related]
3. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.
Christopher L; Marras C; Duff-Canning S; Koshimori Y; Chen R; Boileau I; Segura B; Monchi O; Lang AE; Rusjan P; Houle S; Strafella AP
Brain; 2014 Feb; 137(Pt 2):565-75. PubMed ID: 24334314
[TBL] [Abstract][Full Text] [Related]
4. Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: an in vivo 11C-raclopride PET study.
Politis M; Piccini P; Pavese N; Koh SB; Brooks DJ
Exp Neurol; 2008 Nov; 214(1):112-6. PubMed ID: 18723016
[TBL] [Abstract][Full Text] [Related]
5. A link between synaptic plasticity and reorganization of brain activity in Parkinson's disease.
Rebelo D; Oliveira F; Abrunhosa A; Januário C; Lemos J; Castelo-Branco M
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33431672
[TBL] [Abstract][Full Text] [Related]
6. Cognitive slowing in Parkinson's disease is related to frontostriatal dopaminergic dysfunction.
Jokinen P; Karrasch M; Brück A; Johansson J; Bergman J; Rinne JO
J Neurol Sci; 2013 Jun; 329(1-2):23-8. PubMed ID: 23561982
[TBL] [Abstract][Full Text] [Related]
7. Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA.
Cropley VL; Fujita M; Bara-Jimenez W; Brown AK; Zhang XY; Sangare J; Herscovitch P; Pike VW; Hallett M; Nathan PJ; Innis RB
Psychiatry Res; 2008 Jul; 163(2):171-82. PubMed ID: 18504119
[TBL] [Abstract][Full Text] [Related]
8. Signal transduction pathway activity compensates dopamine D₂/D₃ receptor density changes in Parkinson's disease: a preliminary comparative human brain receptor autoradiography study with [³H]raclopride and [³⁵S]GTPγS.
Farkas S; Nagy K; Jia Z; Hortobágyi T; Varrone A; Halldin C; Csiba L; Gulyás B
Brain Res; 2012 May; 1453():56-63. PubMed ID: 22480734
[TBL] [Abstract][Full Text] [Related]
9. Chronic exposure to dopamine agonists affects the integrity of striatal D
Politis M; Wilson H; Wu K; Brooks DJ; Piccini P
Neuroimage Clin; 2017; 16():455-460. PubMed ID: 28879087
[TBL] [Abstract][Full Text] [Related]
10. Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease.
Ouchi Y; Kanno T; Okada H; Yoshikawa E; Futatsubashi M; Nobezawa S; Torizuka T; Tanaka K
Brain; 2001 Apr; 124(Pt 4):784-92. PubMed ID: 11287377
[TBL] [Abstract][Full Text] [Related]
11. Prefrontal dopaminergic receptor abnormalities and executive functions in Parkinson's disease.
Ko JH; Antonelli F; Monchi O; Ray N; Rusjan P; Houle S; Lang AE; Christopher L; Strafella AP
Hum Brain Mapp; 2013 Jul; 34(7):1591-604. PubMed ID: 22331665
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease.
Jahanshahi M; Jones CR; Zijlmans J; Katzenschlager R; Lee L; Quinn N; Frith CD; Lees AJ
Brain; 2010 Mar; 133(Pt 3):727-45. PubMed ID: 20305278
[TBL] [Abstract][Full Text] [Related]
13. Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study.
Rinne JO; Portin R; Ruottinen H; Nurmi E; Bergman J; Haaparanta M; Solin O
Arch Neurol; 2000 Apr; 57(4):470-5. PubMed ID: 10768619
[TBL] [Abstract][Full Text] [Related]
14. Functional imaging of cognition in Parkinson's disease.
Carbon M; Marié RM
Curr Opin Neurol; 2003 Aug; 16(4):475-80. PubMed ID: 12869806
[TBL] [Abstract][Full Text] [Related]
15. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
[TBL] [Abstract][Full Text] [Related]
16. Striatal dopaminergic dysfunction at rest and during task performance in writer's cramp.
Berman BD; Hallett M; Herscovitch P; Simonyan K
Brain; 2013 Dec; 136(Pt 12):3645-58. PubMed ID: 24148273
[TBL] [Abstract][Full Text] [Related]
17. Cognitive deficits and striatal dopaminergic denervation in Parkinson's disease: a single photon emission computed tomography study using 123iodine-beta-CIT in patients on and off levodopa.
Duchesne N; Soucy JP; Masson H; Chouinard S; Bédard MA
Clin Neuropharmacol; 2002; 25(4):216-24. PubMed ID: 12151909
[TBL] [Abstract][Full Text] [Related]
18. Imaging in Parkinson's disease: the role of monoamines in behavior.
Brooks DJ; Piccini P
Biol Psychiatry; 2006 May; 59(10):908-18. PubMed ID: 16581032
[TBL] [Abstract][Full Text] [Related]
19. Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.
Tedroff J; Pedersen M; Aquilonius SM; Hartvig P; Jacobsson G; Långström B
Neurology; 1996 May; 46(5):1430-6. PubMed ID: 8628494
[TBL] [Abstract][Full Text] [Related]
20. Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson disease.
Christopher L; Duff-Canning S; Koshimori Y; Segura B; Boileau I; Chen R; Lang AE; Houle S; Rusjan P; Strafella AP
Ann Neurol; 2015 Feb; 77(2):269-80. PubMed ID: 25448687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
